- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 24.10. | CDC unleashes 'Wild to Mild' campaign again to boost flu vaccination rates | ||
| 24.10. | Marinus to trim workforce, weigh 'strategic alternatives' after another Ztalmy trial miss sends shares tumbling | ||
| 24.10. | Moderna mounts campaign to tackle low awareness of vaccine eligibility | ||
| 24.10. | GSK answers Pfizer's RSV approval with data targeting matching nod in younger adults | ||
| 24.10. | CDMO Rentschler sets out on 3-year expansion of German HQ site | ||
| 24.10. | In boon for Pfizer and Merck, CDC panel backs expanded use of pneumococcal vaccines | ||
| 23.10. | Novo Nordisk asks FDA to prevent compounders from making copycat versions of GLP-1 star semaglutide | ||
| 23.10. | Anyone with lungs can get cancer, warns hard-hitting new campaign backed by Big Pharma giants | ||
| 23.10. | Roche CEO says Novo's Catalent buyout 'could be a problem' for smaller drugmakers | ||
| 23.10. | Roche's Vabysmo will rise above Eylea biosim threat, exec says, as DMD gene therapy Elevidys delivers sales surprise | ||
| 23.10. | With expanded FDA nod for RSV shot Abrysvo, Pfizer gains edge on GSK's Arexvy. But will it amount to much? | ||
| 23.10. | Red light, green light: England's NICE not sold on Lilly's Kisunla despite UK approval | ||
| 23.10. | Amgen pledges to launch Eylea biosim after legal win-but Regeneron stresses the fight's not over yet | ||
| 23.10. | ICR unites Westwicke and Consilium units under single healthcare brand | ||
| 23.10. | Ogilvy Health names former Avalere exec Mario Muredda CEO as Kim Johnson hits the exit | ||
| 23.10. | Amid geopolitical risk, Legend sheds Genscript as majority shareholder | ||
| 23.10. | Pfizer lays off 75 more workers in North Carolina in wake of late-stage DMD trial fail | ||
| 22.10. | Senators probe whether Pfizer, Lilly DTC platforms create 'potential for inappropriate prescribing' | ||
| 22.10. | Savara sponsors Lifetime talk show episode about rare respiratory disease ahead of FDA submission | ||
| 22.10. | Telix unveils radiopharmaceutical spinoff Rhine Pharma following string of nuclear medicine acquisitions | ||
| 22.10. | DOJ challenges Johnson & Johnson's talc bankruptcy attempt in Texas | ||
| 22.10. | MacroGenics passes off struggling breast cancer med Margenza to TerSera for $40M plus milestones | ||
| 22.10. | Starboard wants to hold Pfizer leadership 'accountable' for overpaid M&A deals, poor return on R&D investment | ||
| 22.10. | Reckitt's Mucinex inspires consumers to swipe left on cold and flu symptoms with Mr. Mucus' Tinder debut | ||
| 22.10. | CDMO Samsung Biologics bags $1.2B production contract, bringing total 2024 deal value to $3.3B+ |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
